Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

US8703775B2 · kind B2 · utility

Assignee

• Abb Vie Deutschland Gmbh & Co. KG · DE

Inventors

• Thorsten Oost · Biberach an der Riß, DE
• Astrid Netz · Mannheim, DE
• Hervé Geneste · Schifferstadt, DE
• Wilfried Braje · Ludwigshafen, DE
• Wolfgang Wernet · Ludwigshafen, DE
• Liliane Unger · Ludwigshafen, DE
• Wilfried Hornberger · Wiesbaden, DE
• Wilfried Lubisch · Mannheim, DE

Key dates

• Filing date: Dec 5, 2008
• Grant date: Apr 22, 2014
• Expiry date: Dec 5, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel amidomethyl-substituted oxindole derivatives, pharmaceutical compositions comprising them, and their use for the treatment of vasopressin-dependent disorders.